Current Prices from bioAffinity Technologies, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	BIAF	USD	09.06.2025 23:59	0,30 USD	0,28 USD +5,89 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	3,45 %	48,51 %	-17,26 %	-72,22 %	-86,96 %	-96,39 %

Company Profile for bioAffinity Technologies, Inc. - Common Stock Share

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

Company Data

Name bioAffinity Technologies, Inc. - Common Stock

Company bioAffinity Technologies, Inc.

Symbol BIAF

Website https://www.bioaffinitytech.com

Primary Exchange

NASDAQ

ISIN US09076W1099

Asset Class Share

Sector Healthcare

Industry Medical - Diagnostics & Research

CEO Ms. Maria Zannes J.D.

Country United States of America

Currency USD

Employees 0,1 T

Address 22211 West Interstate 10, 78257 San Antonio

IPO Date 2022-09-01

Ticker Symbols

Name	Symbol
NASDAQ	BIAF

More Shares

Investors who bioAffinity Technologies, Inc. - Common Stock hold also have the following shares in their portfolio:

GLENC.CAP.F. 21/29 MTN Bond

GLOBAL X HEALTH & WELLNESS ETF ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog